Coccidiosis is a widespread disease that is caused by a single cell parasite called Coccidian protozoa. It can be seen only through the microscope. Every livestock species as well as wild animals can be infected by coccidiosis, which is particularly prevalent at the time of grouping together of the animals and birds in significant numbers. This disease damages the mucosal tissues and sub-mucosal tissues present in the intestinal tract of the animals and birds. Also, this disease leads to decrease in the production of egg in the chicken and also responsible giving the mortality in the flock. Usually there are three to four species present, which can be held responsible for the outbreak of the disease. The less or more the severity of the disease depends on the number of oocytes ingested and on the species of coccidia. The anticoccidial agents are the drugs that stops the progression of the coccidiosis in animals or birds. The anticoccidials are administered in the feed to prevent the disease condition and to minimize the economic loss that is often associated with sub-acute infections. The anticoccidial drugs are used as a prophylactic treatment many a times as most of the damage may be occurred that too before the clinical signs become discernible.
COVID-19 Scenario analysis:
The coronavirus pandemic is having a huge impact on businesses and has already caused an unprecedented collapse of economic activities. The COVID-19 impact is straining the healthcare systems globally. Rapid increase in demand for healthcare facilities and healthcare workers may leave only a few healthcare systems to fulfil the increasing demand during the pandemic situation.
The COVID-19 pandemic cases are because of direct or indirect contact between humans. There has been no evidence or confirmation that animals can spread COVID-19 to humans. The myth animals can spread the virus to humans has increased the number of abandoned pets. Furthermore, COVID-19 has weakened the supply chain and has created shortage of animal health products such as nutritional feed as well as vaccines globally. The animal health industry has been impacted largely as many manufacturers in animal health industry are left with a significantly reduced workforce. Also, stringent government policies such as restrictions of import of raw materials from China is expected to hamper the animal health market.
Healthcare facilities are stocking up the animal related health products, considering the high demand. This is expected to further create financial strain on the market due to procurement inefficiencies and wasted speeding. Due to the pandemic situation, many hospitals and veterinary clinics are overstocking the products.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Increase in development of advanced anticoccidial medicines and increase in the government initiatives can propel the growth of the anticoccidial drugs market. In recent years, the companies have started to outsource the development of the drug which also propels the growth of the anticoccidial drug market. The change in lifestyle and high demand of animal protein food such as meat, milk, and others, are responsible for the market growth. The rapid development of pharmaceutical and biotechnology industries can also lead to the growth of the anticoccidial drugs market.
However, the use of alternative treatments, such as vaccines and herbal medicines to treat coccidiosis is hampering the growth of the anticoccidial drugs market across the world.
New product launches to flourish the market:
On September 09, 2019, Virbac S.A. launched Multimin injection that is used for cattle. This is the prescription-only for preventing the imbalance or detoxifying the harmful effects that can lead to tissue damage that affects cattle’s performance. This Multimin injection manages at the high call in the dairy of beef cattle and dairies like breeding, calving, vaccination. Once it is done, it reaches the blood and liver, and this is very quick, simple, and accurate to improve the health of the cattle.
In April 2019, Creative Diagnostics announced the launch of a series of innovative anticoccidial drugs analysis services and products.
Surge in the usage of anticoccidial drugs:
Rise in government initiatives and approvals from the regulatory associations for the development of the anticoccidial drugs can help to surge the usage of the anticoccidial drugs. Also, rise in awareness about the new products available at affordable rates can also help to surge its usage.
Key benefits of the report:
- This study presents the analytical depiction of the global anticoccidial drugs industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global anticoccidial drugs market share.
- The current market is quantitatively analyzed to highlight the global anticoccidial drugs market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global anticoccidial drugs market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Anticoccidial Drugs Market research report:
- Which are the leading market players active in the anticoccidial drugs market?
- What current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Anticoccidial drug Market Report Highlights
| Aspects | Details |
 By Drug Type |
|
 By Drug action |
|
 By Animal type |
|
 By Region |
|
 Key Market Players | Vetoquinol S.A. and Virbac S.A, Others., Venkateshwara hatcheries Pvt. Ltd., Zoetis, Inc., Boehringer Ingelheim international GmbH, Ceva Sante Animale, Huvepharma EOOD, Merck & Co., Inc, Bayer AG |
Loading Table Of Content...
